| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 126, 765-772, Copyright © 1990 by Endocrine Society
ARTICLES |
JD White, D Olchovsky, M Kershaw and M Berelowitz
Department of Medicine, State University of New York, Stony Brook 11794.
Neuropeptide-Y (NPY) is a 36-amino acid C-terminally amidated peptide found within the hypothalamus that can potently stimulate carbohydrate feeding. Moreover, the hypothalamic content of NPY can be modulated by peripheral hetabolic status. To further evaluate the regulation of NPY synthesis in states of altered metabolic homeostasis, we measured the hypothalamic content of prepro-NPY mRNA in streptozocin (STZ)-diabetic, STZ-diabetic insulin-replaced, and control rats by both nuclease protection and in situ hybridization analyses. Adult male Sprague- Dawley rats received a single injection of STZ (100 mg/kg, ip) or citric acid (control). Beginning 72 h later one group of STZ-treated animals received daily injections of insulin (4 U Ultralente/day). All animals were killed 17-19 days after STZ or control treatment. STZ- treated animals were hyperglycernic and showed growth failure compared to control rats. Glycemic control was restored by insulin replacement, as was partial growth. Nuclease protection analysis revealed an approximately 3- to 4-fold increase in prepro-NPY mRNA levels in the samples from STZ-treated rats vs. control. This increase was returned to control values by insulin replacement. In situ hybridization analysis revealed the STZ-induced increase in hypothalamic prepro-NPY mRNA was detectable in the arcuate nucleus at levels that were in agreement with the nuclease protection results, but that NPY expression in other brain regions appeared to be either unaffected or decreased after STZ treatment. These data suggest that hypothalamic NPY expression is modulated by peripheral metabolic status and provide further explanation for the hyperphagia accompanying STZ-induced diabetes.
This article has been cited by other articles:
![]() |
D. Porte Jr. Central Regulation of Energy Homeostasis: The Key Role of Insulin Diabetes, December 1, 2006; 55(Supplement_2): S155 - S160. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-J. D. Lin, A. Sainsbury, N. J. Lee, D. Boey, M. Couzens, R. Enriquez, K. Slack, R. Bland, M. J. During, and H. Herzog Combined Deletion of Y1, Y2, and Y4 Receptors Prevents Hypothalamic Neuropeptide Y Overexpression-Induced Hyperinsulinemia despite Persistence of Hyperphagia and Obesity Endocrinology, November 1, 2006; 147(11): 5094 - 5101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dong, T. L. Peeters, B. De Smet, D. Moechars, C. Delporte, P. Vanden Berghe, B. Coulie, M. Tang, and I. Depoortere Role of Endogenous Ghrelin in the Hyperphagia of Mice with Streptozotocin-Induced Diabetes Endocrinology, June 1, 2006; 147(6): 2634 - 2642. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Kim, S Sohn, M Lee, J Jung, R D Kineman, and S Park Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes J. Endocrinol., February 1, 2006; 188(2): 263 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stanley, K. Wynne, B. McGowan, and S. Bloom Hormonal Regulation of Food Intake Physiol Rev, October 1, 2005; 85(4): 1131 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wynne, S. Stanley, B. McGowan, and S. Bloom Appetite control J. Endocrinol., February 1, 2005; 184(2): 291 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Tkacs and B. E. Levin Obesity-prone rats have preexisting defects in their counterregulatory response to insulin-induced hypoglycemia Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1110 - R1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Gelling, J. Overduin, C. D. Morrison, G. J. Morton, R. S. Frayo, D. E. Cummings, and M. W. Schwartz Effect of Uncontrolled Diabetes on Plasma Ghrelin Concentrations and Ghrelin-Induced Feeding Endocrinology, October 1, 2004; 145(10): 4575 - 4582. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. la Fleur, H. Ji, S. L. Manalo, M. I. Friedman, and M. F. Dallman The Hepatic Vagus Mediates Fat-Induced Inhibition of Diabetic Hyperphagia Diabetes, September 1, 2003; 52(9): 2321 - 2330. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Figlewicz Adiposity signals and food reward: expanding the CNS roles of insulin and leptin Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R882 - R892. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Sindelar, P. Mystkowski, D. J. Marsh, R. D. Palmiter, and M. W. Schwartz Attenuation of Diabetic Hyperphagia in Neuropeptide Y-Deficient Mice Diabetes, March 1, 2002; 51(3): 778 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kanatani, M. Hata, S. Mashiko, A. Ishihara, O. Okamoto, Y. Haga, T. Ohe, T. Kanno, N. Murai, Y. Ishii, et al. A Typical Y1 Receptor Regulates Feeding Behaviors: Effects of a Potent and Selective Y1 Antagonist, J-115814 Mol. Pharmacol., March 1, 2001; 59(3): 501 - 505. [Abstract] [Full Text] |
||||
![]() |
B. E. Levin and A. A. Dunn-Meynell Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2222 - R2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Park, J. Kamegai, T. A. Johnson, L. A. Frohman, and R. D. Kineman Modulation of Pituitary Somatostatin Receptor Subtype (sst1-5) Messenger Ribonucleic Acid Levels by Changes in the Growth Hormone Axis Endocrinology, October 1, 2000; 141(10): 3556 - 3563. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wahren, K. Ekberg, J. Johansson, M. Henriksson, A. Pramanik, B.-L. Johansson, R. Rigler, and H. Jornvall Role of C-peptide in human physiology Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E759 - E768. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kanatani, S. Mashiko, N. Murai, N. Sugimoto, J. Ito, T. Fukuroda, T. Fukami, N. Morin, D. J. MacNeil, L. H. T. Van der Ploeg, et al. Role of the Y1 Receptor in the Regulation of Neuropeptide Y-Mediated Feeding: Comparison of Wild-Type, Y1 Receptor-Deficient, and Y5 Receptor-Deficient Mice Endocrinology, March 1, 2000; 141(3): 1011 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Larsen, M. Tang-Christensen, C. E. Stidsen, K. Madsen, M. S. Smith, and J. L. Cameron Activation of Central Neuropeptide Y Y1 Receptors Potently Stimulates Food Intake in Male Rhesus Monkeys J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3781 - 3791. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xu, P. S. Kalra, W. G. Farmerie, and S. P. Kalra Daily Changes in Hypothalamic Gene Expression of Neuropeptide Y, Galanin, Proopiomelanocortin, and Adipocyte Leptin Gene Expression and Secretion: Effects of Food Restriction Endocrinology, June 1, 1999; 140(6): 2868 - 2875. [Abstract] [Full Text] |
||||
![]() |
B. E. Levin, A. A. Dunn-Meynell, and V. H. Routh Brain glucose sensing and body energy homeostasis: role in obesity and diabetes Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1223 - R1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-M. Kim, M. K. Grace, C. C. Welch, C. J. Billington, and A. S. Levine STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1320 - R1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W Schwartz, D. G Baskin, K. J Kaiyala, and S. C Woods Model for the regulation of energy balance and adiposity by the central nervous system Am. J. Clinical Nutrition, April 1, 1999; 69(4): 584 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Kalra, M. G. Dube, S. Pu, B. Xu, T. L. Horvath, and P. S. Kalra Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight Endocr. Rev., February 1, 1999; 20(1): 68 - 100. [Abstract] [Full Text] |
||||
![]() |
P. J. Havel, J. Y. Uriu-Hare, T. Liu, K. L. Stanhope, J. S. Stern, C. L. Keen, and B. Ahren Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1482 - R1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kesterson, D. Huszar, C. A. Lynch, R. B. Simerly, and R. D. Cone Induction of Neuropeptide Y Gene Expression in the Dorsal Medial Hypothalamic Nucleus in Two Models of the Agouti Obesity Syndrome Mol. Endocrinol., May 1, 1997; 11(5): 630 - 637. [Abstract] [Full Text] |
||||
![]() |
G. Barrera-Hernandez, I. E. Wanke, and N. C. W. Wong Effects of Diabetes Mellitus on Hepatocyte Nuclear Factor 1 Decrease Albumin Gene Transcription J. Biol. Chem., April 26, 1996; 271(17): 9969 - 9975. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |